Skip to content Back to top
 

FOI2026/2091

Reference FOI2026/2091
Description Guidelines on the Treatment of Interstitial Lung Diseases (ILD)
Date Requested 12/10/2026
Date Replied 19/10/2026
Category Medicines Optimisation

Please find below a freedom of information request relating to clinical guidelines for the treatment of interstitial lung diseases (ILD).

This request is in follow up to a previous related request submitted in April 2023 and has been prompted by recent developments in the treatments of these conditions.

Question 1

Has NHS Greater Manchester ICB published or updated any local treatment guidelines, pathways or protocols for the treatment of the interstitial lung diseases (ILD), idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) since April 2023? Yes/No
If Yes, please provide a copy.

  1. No – NHS Greater Manchester has not published or updated any local treatment guidelines, pathways or protocols for interstitial lung disease, idiopathic pulmonary fibrosis or progressive pulmonary fibrosis since April 2023.

All Greater Manchester ICB medicines guidelines, pathways and protocols are publicly available on the Greater Manchester Medicines Management Group (GMMMG) website which can be accessed via: https://gmmmg.nhs.uk/

Return to FOI Requests

Launch Recite Me assistive technology